Biodesix Financial Statements From 2010 to 2025

BDSX Stock  USD 0.76  0.01  1.33%   
Biodesix financial statements provide useful quarterly and yearly information to potential Biodesix investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Biodesix financial statements helps investors assess Biodesix's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Biodesix's valuation are summarized below:
Gross Profit
55.8 M
Profit Margin
(0.60)
Market Capitalization
109.5 M
Enterprise Value Revenue
2.0387
Revenue
71.3 M
We have found one hundred twenty available fundamental signals for Biodesix, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Biodesix prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 105.8 M in 2025. Enterprise Value is likely to drop to about 93.5 M in 2025

Biodesix Total Revenue

47.72 Million

Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 3.2 M or Interest Expense of 6.9 M, as well as many indicators such as Price To Sales Ratio of 2.64, Dividend Yield of 0.0 or PTB Ratio of 7.36. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.
  
Check out the analysis of Biodesix Correlation against competitors.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Biodesix Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets89.1 M97.2 M60.5 M
Slightly volatile
Short and Long Term Debt Total39.5 M62 M29.7 M
Slightly volatile
Other Current Liabilities15.9 M10.7 M8.9 M
Slightly volatile
Total Current Liabilities24.9 M14.3 M13.7 M
Slightly volatile
Other Liabilities19.8 M17.3 M24 M
Slightly volatile
Property Plant And Equipment Net31.1 M29.6 M7.6 M
Slightly volatile
Current Deferred RevenueM678 K881.2 K
Slightly volatile
Accounts Payable2.3 M2.2 M1.8 M
Slightly volatile
Cash31.7 M26.2 M17.5 M
Slightly volatile
Non Current Assets Total44.4 M57.8 M35 M
Slightly volatile
Non Currrent Assets OtherM7.3 M1.9 M
Slightly volatile
Other Assets7.2 M6.8 MM
Slightly volatile
Long Term Debt26.6 M36.4 M23.8 M
Slightly volatile
Cash And Short Term Investments31.7 M26.2 M17.5 M
Slightly volatile
Net Receivables7.5 M8.6 M4.4 M
Slightly volatile
Good Will15.3 M17.3 M12.6 M
Slightly volatile
Common Stock Total Equity32.6 K31.1 K11.4 K
Slightly volatile
Common Stock Shares Outstanding136.2 M129.7 M42.5 M
Slightly volatile
Liabilities And Stockholders Equity89.1 M97.2 M60.5 M
Slightly volatile
Non Current Liabilities Total83.2 M62.1 M167 M
Slightly volatile
Inventory1.9 M1.6 M1.2 M
Slightly volatile
Other Current Assets4.2 M4.6 MM
Slightly volatile
Other Stockholder Equity321.8 M483.2 M151.9 M
Slightly volatile
Total Liabilities101.3 M76.4 M180.3 M
Slightly volatile
Property Plant And Equipment Gross40.7 M38.7 M9.1 M
Slightly volatile
Total Current Assets44.8 M39.5 M25.6 M
Slightly volatile
Capital Stock152.2 K145 K33.7 K
Slightly volatile
Non Current Liabilities Other774.2 K815 K20.5 M
Slightly volatile
Intangible Assets9.2 M5.9 M14 M
Slightly volatile
Common Stock152.2 K145 K33.7 K
Slightly volatile
Property Plant Equipment10.7 M10.1 M3.8 M
Slightly volatile
Short and Long Term Debt19.9 K21 K8.3 M
Slightly volatile
Short Term Debt703 K740 K8.6 M
Slightly volatile
Deferred Long Term Liabilities523.2 K588.6 K641.7 K
Slightly volatile

Biodesix Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income25.9 K16.2 K24.1 K
Pretty Stable
Depreciation And Amortization3.2 M6.3 M2.6 M
Slightly volatile
Interest Expense6.9 M8.3 M4.6 M
Slightly volatile
Selling General Administrative55.2 M80.5 M38.4 M
Slightly volatile
Selling And Marketing Expenses44.7 M70.7 M36.7 M
Slightly volatile
Total Revenue47.7 M71.3 M32.2 M
Slightly volatile
Gross Profit74.9 M71.3 M26 M
Slightly volatile
Other Operating Expenses83.6 M105.8 M57.7 M
Slightly volatile
Research Development11.8 M9.6 M9.5 M
Slightly volatile
Cost Of Revenue16.6 M15.6 M9.8 M
Slightly volatile
Total Operating Expenses69.5 M105.8 M49 M
Slightly volatile
Reconciled Depreciation4.4 M5.5 M2.9 M
Slightly volatile
Income Tax Expense5.1 M6.1 M2.5 M
Slightly volatile

Biodesix Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation4.2 M6.6 MM
Slightly volatile
Begin Period Cash Flow28.5 M26.4 M15.8 M
Slightly volatile
Depreciation4.3 M5.5 M2.9 M
Slightly volatile
Other Non Cash Items7.3 M3.9 M6.5 M
Pretty Stable
Capital Expenditures5.7 M3.2 MM
Slightly volatile
Issuance Of Capital Stock43.9 M55.6 M24.4 M
Slightly volatile
Total Cash From Financing Activities41.6 M52 M28.6 M
Slightly volatile
End Period Cash Flow31.8 M26.3 M17.7 M
Slightly volatile
Change To Netincome22.9 M21.8 M10.1 M
Slightly volatile
Sale Purchase Of Stock536.5 K625 K381 K
Slightly volatile
Dividends Paid534 K739.5 K406 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.642.781611.7817
Slightly volatile
Days Sales Outstanding64.2844.026446.4842
Slightly volatile
Stock Based Compensation To Revenue0.06220.09310.0414
Slightly volatile
Capex To Depreciation0.890.5920.7203
Slightly volatile
EV To Sales3.123.282612.3465
Slightly volatile
Inventory Turnover6.768.367.2601
Slightly volatile
Days Of Inventory On Hand49.3645.1751.7291
Slightly volatile
Payables Turnover5.624.05.7232
Pretty Stable
Sales General And Administrative To Revenue1.391.441.2798
Slightly volatile
Research And Ddevelopement To Revenue0.130.1340.3322
Slightly volatile
Capex To Revenue0.0880.04530.07
Slightly volatile
Cash Per Share0.190.20240.4677
Slightly volatile
Days Payables Outstanding86.3294.577.426
Very volatile
Income Quality0.571.13320.6845
Very volatile
Intangibles To Total Assets0.420.2150.5458
Slightly volatile
Current Ratio1.512.75782.0317
Pretty Stable
Receivables Turnover6.358.29059.2684
Slightly volatile
Capex Per Share0.02370.02490.0533
Slightly volatile
Revenue Per Share0.520.550.8859
Pretty Stable
Interest Debt Per Share1.060.54160.9761
Pretty Stable
Debt To Assets0.540.63730.5425
Pretty Stable
Operating Cycle41.8344.026490.9021
Pretty Stable
Days Of Payables Outstanding86.3294.577.426
Very volatile
Ebt Per Ebit1.011.24441.1702
Slightly volatile
Quick Ratio1.462.75781.9193
Pretty Stable
Net Income Per E B T0.891.111.0535
Slightly volatile
Cash Ratio1.041.83311.2973
Very volatile
Cash Conversion Cycle23.7144.026423.6449
Slightly volatile
Days Of Inventory Outstanding49.3645.1751.7291
Slightly volatile
Days Of Sales Outstanding64.2844.026446.4842
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.971.06641.1059
Slightly volatile
Fixed Asset Turnover2.292.4111.3833
Slightly volatile
Debt Ratio0.540.63730.5425
Pretty Stable
Price Sales Ratio2.642.781611.7817
Slightly volatile
Asset Turnover0.440.73340.5294
Very volatile
Gross Profit Margin0.70.850.7302
Slightly volatile

Biodesix Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap105.8 M111.4 M289.9 M
Slightly volatile
Enterprise Value93.5 M98.4 M291.6 M
Slightly volatile

Biodesix Fundamental Market Drivers

Cash And Short Term Investments26.2 M

Biodesix Upcoming Events

4th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Biodesix Financial Statements

Biodesix investors use historical fundamental indicators, such as Biodesix's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue678 KM
Total Revenue71.3 M47.7 M
Cost Of Revenue15.6 M16.6 M
Stock Based Compensation To Revenue 0.09  0.06 
Sales General And Administrative To Revenue 1.44  1.39 
Research And Ddevelopement To Revenue 0.13  0.13 
Capex To Revenue 0.05  0.09 
Revenue Per Share 0.55  0.52 
Ebit Per Revenue(0.48)(0.51)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.